NCT04531540View on ClinicalTrials.gov

Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test)

PHASE3CompletedINTERVENTIONAL

Enrollment

225

Participants

Timeline

Start Date

September 9, 2013

Primary Completion Date

October 18, 2013

Study Completion Date

October 18, 2013

Conditions

Hypersensitivity

Interventions

DRUG

Butenafine HCl 1% (BAY1896425)

Approximately 0.2 g of cream containing butenafine HCl 1% were applied to the upper back skin.

Trial Locations (1)

07004

Fairfield

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY